For instance, Chen et al. reportedthe use of an 89Zr-labeled anti-Trop2 monoclonal antibody(DFO-AF650), which achieved a tumor uptake value of 28.8 ± 7.63%ID/gin BxPC3 pancreatic xenografts at 120 h. The gene discussed is TACSTD2; the disease is neoplasm.